Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Ansbert Gadicke

10% Owner at Aktis Oncology, Inc. (AKTS)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-14.3%
vs. S&P 500-15.1%
Beat the market0%
Paper profit on buys+$167K
Total bought / sold$20.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Jan 14SEC AKTSAktis Oncology, Inc. Buy 1,112,77710,260,064 held (+12%) $18.00 $20.0M +0.8%
  • Buy

    10% Owner Ansbert Gadicke bought $20.0M of AKTS at $18.00 — first open-market purchase in our records.